Professor Luesley is currently the Professor of Gynaecological Oncology at the University of Birmingham, UK, having graduated from Cambridge University and then Birmingham University Medical School in 1975. David became a fellow of the Royal College of Obstetricians and Gynaecologists in 1990 and was awarded the Victor Bonney prize by his college in 2002 and the Founders medal by the BSCCP in 2008.
Since completing his clinical research fellowship in Gynaecological Oncology at the University of Birmingham (1980) he has remained research and clinically active in this field as well as directing Undergraduate Education in Obstetrics & Gynaecology. David has undertaken many roles at a regional, national and international level and have most recently focussed on improving educational standards in his subspecialty. He co-founded the subspecialty programme in Birmingham 20 years ago and has provided both clinical and research training to in excess of 30 UK and overseas postgraduates. He is a past president of the BSCCP and BGCS and during his term as president of the BSCCP introduced accreditation and a structured curriculum.
David was the first director of the Pan-Birmingham Gynaecological Cancer Centre when launched in 2005 and over the last 5 years the centre has become one of the largest in the UK and has gained an international reputation for high clinical standards and active participation in research.
His clinical and research interests include gynaecological oncology and vulvar disease.
Total: 114 Total in last 5 yrs: 30
Total: 44 Total in last 5 yrs: 5
Chapters in Books
Total: 36 Total in last 5 yrs: 13
Total: 19 Total in last 5 yrs: 12
Management of women who test positive for high risk types of human papillomaviruses: the HART study. (2003) Cuzick J., Szarewski A., Cubie H., Hulman G., Kitchener H., Luesley D et al. Lancet 362: 1871-76.
Lack of antibody responses to HPV-16 virus-like particles in women with CIN infected with a variant strain of HPV-16. (1997) Ellis J., Etherington IJ., Galloway D., Luesley DM and Young LS. Lancet (1997); 349: 1069-1070.
LLETZ-Evidence of its efficacy against HPV infection (2001) Mann CH., Steele JC., Burton A., Bailey AS., Etherington IJ and Luesley DM. Gynecol Oncol. 81:125-127.
Human papillomavirus (HPV) type 16-specific CD8+ T cell responses in women with high grade vulvar intraepithelial neoplasia Todd, R. W., Roberts, S., Mann, C. H., Luesley, D. M., Gallimore, P. H., & Steele, J. C. 2004a Int.J.Cancer, vol. 108, no. 6, pp. 857-862
Detection of CD8+ T cell responses to human papillomavirus type 16 antigens in women using imiquimod as a treatment for high-grade vulval intraepithelial neoplasia Todd, R. W., Steele, J. C., Etherington, I., & Luesley, D. M. 2004b, Gynecol.Oncol., vol. 92, no. 1, pp. 167-174.
Characterizing T-cell response in low-grade and high-grade vulval intraepithelial neoplasia, study of CD3, CD4 and CD8 expressions. (2004). Gul N., Ganesan R and Luesley DM. Gynecol.Oncol 94; 48-53
Women's experience of colposcopy: a qualitative investigation.Swancutt DR, Greenfield SM, Luesley DM, Wilson S.BMC Womens Health. 2011 Apr 13;11(1):11. [Epub ahead of print
Indication and outcome of repeat large loop excision biopsies of the cervix.Moss EL, Appleyard TL, Winning JM, Jones PW, Luesley DM. J Low Genit Tract Dis. 2011 Apr;15(2):89-92
Obstetrics and Gynaecology: an evidence-based text for the MRCOG. Second Edition Eds David M Luesley and Philip N Baker. Arnold. London 2010